calcipotriene and betamethasone dipropionate

FDA Drug Profile — TACLONEX, ENSTILAR, Attero, calcipotriene and betamethasone dipropionate

calcipotriene and betamethasone dipropionate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including TACLONEX, ENSTILAR, Attero. Available dosage forms: suspension, aerosol, foam, solution.

Drug Details

Generic Name
calcipotriene and betamethasone dipropionate
Brand Names
TACLONEX, ENSTILAR, Attero, calcipotriene and betamethasone dipropionate
Application Number
NDA022185
Sponsor
LEO Pharma Inc.
NDC Codes
4
Dosage Forms
SUSPENSION, AEROSOL, FOAM, SOLUTION
Routes
TOPICAL
Active Ingredients
CALCIPOTRIENE HYDRATE, BETAMETHASONE DIPROPIONATE, CALCIPOTRIENE MONOHYDRATE, CALCIPOTRIENE

Indications and Usage

1 INDICATIONS AND USAGE Taclonex ® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. Taclonex Topical Suspension is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. ( 1 )